Prevalence of Three Prothrombotic Polymorphisms: Factor V G1691A, Factor II G20210A and Methylenetetrahydrofolate Reductase (MTHFR) C 677T in Argentina

Thrombosis Research

Volumn 100, Issue 3, 2000, Pages 127-131

  Genoud, Valeria ^a   Castañon, Mercedes ^a   Annichino Bizzacchi, Joyce ^b   Korin, Jorge ^a   Kordich, Lucía ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Factor V Leiden; MTHFR; Prevalence; Prothrombin 20210; Thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5 LEIDEN; DNA FRAGMENT; HOMOCYSTEINE; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; AGED; ARGENTINA; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DNA POLYMORPHISM; GENE MUTATION; GENETIC DISORDER; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; LUNG EMBOLISM; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM; THROMBOPHILIA;

ADULT; AGED; BRAZIL; FACTOR V; GENETIC SCREENING; HETEROZYGOTE; HOMOZYGOTE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POINT MUTATION; POLYMORPHISM, GENETIC; PREVALENCE; PROTHROMBIN; RISK FACTORS; THROMBOPHILIA;

EID: 0034324872     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00314-5     Document Type: Article

References (23)

1. The epidemiology, pathogenesis and natural history of venous thrombosis
2. Inherited Thrombophilia: Pathogenesis, Clinical Syndromes, and Management
3. Oral Contraception and Factor V Leiden Mutation in Relation to Localization of Deep Vein Thrombosis
4. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
5. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke and venous thrombosis in apparently healthy men
6. Resistance to activated Protein C and factor V Leiden as risk factor for venous thrombosis
7. Resistance to activated protein C caused by the factor V R506Q mutation is a common risk factor for venous thrombosis
8. Epidemiology of Factor V Leiden: Clinical implications
9. A common genetic variation in the 3' untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
10. G20210 A mutation in prothrombin gene and risk of myocardial infarction, stroke and venous thrombosis ia a large cohort of US men
11. An Improved Method for the Detection of the G20210A Transition in the Prothrombin Gene
12. Prevalence of the 677C to T mutation in the methylenetetrahydrofolate reductase gene in Italian patients with venous thrombo tic disease
13. Thermolabile methylentetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis
14. The methylenetetrahydrofolate reductase T677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation
15. Search for Genetic Factors Favoring Thrombosis in Turkish Population
16. Factor V Leiden Mutation in the Argentinian Population
17. A rapid non-enzimatic method for the preparation of HMW DNA from blood for RFLP studies
18. Mutation in blood coagulation factor V associated with resistance to activated protein C
19. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
20. The epidemiology of inherited thrombophilia: The VITA project
21. Prevalence of the FV Leiden mutation in the Spanish population
22. Frequency of Factor V (FV) Leiden and C677T Methylenetetrahydrofolate Reductase (MTHFR) mutations in Colombians
23. Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: Prevalence and risk assessment